Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

Cited by (1,000)

Items 101–200 of 1,000

1. The influence of subclonal resistance mutations on targeted cancer therapy
   Michael W. Schmitt, Lawrence A. Loeb, Jesse J. Salk · 2015 · Nature Reviews Clinical Oncology
2. Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma
   De‐Chen Lin, Anand Mayakonda, Huy Q. Dinh, Pinbo Huang, Lehang Lin, Xiaoping Liu, Ling‐Wen Ding, Jie Wang, Benjamin P. Berman, Erwei Song et al. · 2017 · Cancer Research
3. Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts
   Jacqui Shaw, David S. Guttery, Allison Hills, Daniel Fernández-García, Karen Page, Brenda Maria Rosales, Kate S. Goddard, Robert K. Hastings, Jinli Luo, Olivia Ogle et al. · 2016 · Clinical Cancer Research
4. Cancer Genome Evolutionary Trajectories in Metastasis
   Nicolai J. Birkbak, Nicholas McGranahan · 2020 · Cancer Cell
5. Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer
   Marco L. Leung, Alexander Davis, Ruli Gao, Tod D. Casasent, Yong Wang, Emi Sei, Eduardo Vilar, Dipen Maheshbhai Maru, Scott Kopetz, Nicholas E. Navin · 2017 · Genome Research
6. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer
   Emily K. Law, Anieta M. Sieuwerts, Kelly S. LaPara, Brandon C. Leonard, Gabriel J. Starrett, Amy M. Molan, Nuri A. Temiz, Rachel Isaksson Vogel, Marion E. Meijer‐van Gelder, Fred C.G.J. Sweep et al. · 2016 · Science Advances
7. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome
   Deborah R. Caswell, Charles Swanton · 2017 · BMC Medicine
8. The Consequences of Chromosome Segregation Errors in Mitosis and Meiosis
   Tamara Potapova, Gary J. Gorbsky · 2017 · Biology
9. The PIDDosome activates p53 in response to supernumerary centrosomes
   Luca L. Fava, Fabian Schuler, Valentina C. Sladky, Manuel D. Haschka, Claudia Soratroi, Lisa Eiterer, Egon Demetz, Günter Weiß, Stephan Geley, Erich A. Nigg et al. · 2017 · Genes & Development
10. In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer
    Momcilovic, Milica, Jones, Anthony, Bailey, Sean T., Waldmann, Christopher M., Li, Rui, Lee, Jason T., Abdelhady, Gihad, Gomez, Adrian, Holloway, Travis, Schmid, Ernst et al. · 2019 · Nature
11. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study
    Jianxin Shi, Xing Hua, Bin Zhu, Sarangan Ravichandran, Mingyi Wang, Cu Duy Nguyen, Seth A. Brodie, A. Palleschi, Marco Alloisio, Gianluca Pariscenti et al. · 2016 · PLoS Medicine
12. An analysis of genetic heterogeneity in untreated cancers
    Johannes G. Reiter, Marina Baretti, Jeffrey M. Gerold, Alvin P. Makohon-Moore, ADIL I. DAUD, Christine A. Iacobuzio–Donahue, Nilofer Saba Azad, Kenneth W. Kinzler, Martin A. Nowak, Bert Vogelstein · 2019 · Nature reviews. Cancer
13. Spatial biology of cancer evolution
    Zaira Seferbekova, Artem Lomakin, Lucy R. Yates, Moritz Gerstung · 2022 · Nature Reviews Genetics
14. Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
    Jingying Nong, Yuhua Gong, Yanfang Guan, Xin Yi, Yuting Yi, Lianpeng Chang, Ling Yang, Jialin Lv, Zhirong Guo, Hongyan Jia et al. · 2018 · Nature Communications
15. Deregulation of HLA-I in cancer and its central importance for immunotherapy
    Ahmet Hazini, Kerry Fisher, Leonard William Seymour · 2021 · Journal for ImmunoTherapy of Cancer
16. Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications
    Federica Zito Marino, Roberto Bianco, Marina Accardo, Andrea Ronchi, Immacolata Cozzolino, Floriana Morgillo, Giulio Rossi, Renato Franco · 2019 · International Journal of Medical Sciences
17. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
    PDXNET Consortium, Woo, Xing Yi, EurOPDX Consortium, Giordano, Jessica, Srivastava, Anuj, Zhao, Zi-Ming, Lloyd, Michael W., de Bruijn, Roebi, Suh, Yun-Suhk, Patidar, Rajesh et al. · 2021 · Nature Genetics
18. Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia
    Carmen Herling, Nima Abedpour, Jonathan M. Weiss, Anna Schmitt, Ron Daniel Jachimowicz, Olaf Merkel, Maria Cartolano, Sebastian Oberbeck, Petra Mayer, Valeska Berg et al. · 2018 · Nature Communications
19. Cancer Vaccines, Adjuvants, and Delivery Systems
    Paston, Samantha J., Brentville, Victoria A., Symonds, Peter, Durrant, Lindy G. · 2021 · Frontiers in Immunology
20. Advances in molecular pathology and therapy of non-small cell lung cancer
    Huang, Qing, Li, Yuanxiang, Huang, Yingdan, Wu, Jingyi, Bao, Wendai, Xue, Chang, Li, Xiaoyu, Dong, Shuang, Dong, Zhiqiang, Hu, Sheng · 2025 · Signal Transduction and Targeted Therapy
21. Genomic heterogeneity of multiple synchronous lung cancer
    Yu Liu, Jianjun J. Zhang, Li Lin, Guangliang Yin, Jianhua Zhang, Shan Zheng, Hannah C. Beird, Ning Wu, Ning Lü, Xizeng Mao et al. · 2016 · Nature Communications
22. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma
    Xue, Ruidong, Li, Ruoyan, Guo, Hua, Guo, Lin, Su, Zhe, Ni, Xiaohui, Qi, Lisha, Zhang, Ti, Li, Qiang, Zhang, Zemin et al. · 2016 · Gastroenterology
23. Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy
    Weiguo Zhang, Jian‐Hua Mao, Wei Zhu, Anshu K. Jain, Ke Liu, James B. Brown, Gary H. Karpen · 2016 · Nature Communications
24. Novel therapeutic targets on the horizon for lung cancer
    Wan-Ling Tan, Amit Jain, Angela Maria Takano, Evan William Newell, Narayanan Gopalakrishna Iyer, Wan‐Teck Lim, Eng-Huat Tan, Weiwei Zhai, Axel M. Hillmer, Wai Leong Tam et al. · 2016 · The Lancet Oncology
25. A framework for understanding and targeting residual disease in oncogene-driven solid cancers
    Trever Grant Bivona, Robert Charles Doebele · 2016 · Nature Medicine
26. Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
    Maria Vinci, Anna Burford, Valeria Molinari, Ketty Kessler, Sergey Popov, Matthew Clarke, Kathryn R. Taylor, Helen N. Pemberton, Christopher J. Lord, Alice Gutteridge et al. · 2018 · Nature Medicine
27. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication
    Vladimir B. Seplyarskiy, Ruslan Soldatov, Konstantin Yu. Popadin, Stylianos E. Antonarakis, Georgii A. Bazykin, Sergey I. Nikolaev · 2016 · Genome Research
28. Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
    David N. Brown, Dominiek Smeets, Borbála Székely, Denis Larsimont, Attila Marcell Szász, Pierre-Yves Adnet, Françoise Rothé, Ghizlane Rouas, Zsófia Nagy, Zsófia Faragó et al. · 2017 · Nature Communications
29. A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
    Russo, Alessandro, Franchina, Tindara, Rita Ricciardi, Giuseppina Rosaria, Picone, Antonio, Ferraro, Giuseppa, Zanghì, Mariangela, Toscano, Giuseppe, Giordano, Antonio, Adamo, Vincenzo · 2015 · Oncotarget
30. Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing
    Nahar, Rahul, Zhai, Weiwei, Zhang, Tong, Takano, Angela, Khng, Alexis J., Lee, Yin Yeng, Liu, Xingliang, Lim, Chong Hee, Koh, Tina P. T., Aung, Zaw Win et al. · 2018 · Nature Communications
31. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
    Xin Hu, Junya Fujimoto, Lisha Ying, Junya Fukuoka, Kazuto Ashizawa, Wenyong Sun, Alexandre Reuben, Chi-Wan B. Chow, Nicholas McGranahan, Runzhe Chen et al. · 2019 · Nature Communications
32. New Approaches to SCLC Therapy: From the Laboratory to the Clinic
    John Thomas Poirier, Julie George, Taofeek Kunle Owonikoko, Anton J. M. Berns, Elisabeth M. Brambilla, Lauren A. Byers, David Paul Carbone, Huanhuan Joyce Chen, Camilla Laulund Christensen, Caroline Dive et al. · 2020 · Journal of Thoracic Oncology
33. Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine
    Laetitia Seguin, Manon Durandy, Chloé C. Féral · 2022 · Cancers
34. Detecting repeated cancer evolution from multi-region tumor sequencing data
    Giulio Caravagna, Ylenia Giarratano, Daniele Ramazzotti, Ian P.M. Tomlinson, Trevor A. Graham, Guido Sanguinetti, Andrea Sottoriva · 2018 · Nature Methods
35. Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges
    Li‐Chun Lu, Chih‐Hung Hsu, Chiun Hsu, Ann‐Lii Cheng · 2016 · Liver Cancer
36. Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
    Mariam Jamal‐Hanjani, Gareth A. Wilson, Stuart D. Horswell, Richard Mitter, Onur Sakarya, Tudor P. Constantin, Raheleh Salari, Eser Kırkızlar, Styrmir Sigurjonsson, Robert J. Pelham et al. · 2016 · Annals of Oncology
37. Reconstructing metastatic seeding patterns of human cancers
    Johannes G. Reiter, Alvin P. Makohon-Moore, Jeffrey M. Gerold, Ivana Božić, Krishnendu Chatterjee, Christine A. Iacobuzio–Donahue, Bert Vogelstein, Martin A. Nowak · 2017 · Nature Communications
38. Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer
    Jonathan David Spicer, Tina Cascone, Murry W. Wynes, Myung‐Ju Ahn, Sanja Đačić, Enriqueta Felip, Patrick M. Forde, Kristin A. Higgins, Mark G. Kris, Tetsuya Mitsudomi et al. · 2024 · Journal of Thoracic Oncology
39. RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?
    Julian Downward · 2015 · Clinical Cancer Research
40. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer
    Nnennaya Kanu, Maria Antonietta Cerone, Gerald Goh, Lykourgos‐Panagiotis Zalmas, Jiřina Bártková, Michelle Dietzen, Nicholas McGranahan, Rebecca F. Rogers, Emily K. Law, Irina Gromova et al. · 2016 · Genome biology
41. Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma
    Natalie I. Vokes, Emily S. Chambers, Tom T. Nguyen, Alexis Coolidge, Christine Lydon, Xiuning Le, Lynette Marie Sholl, John Victor Heymach, Mizuki Nishino, Eliezer M. Van Allen et al. · 2022 · Journal of Thoracic Oncology
42. Measuring cancer evolution from the genome
    Trevor A. Graham, Andrea Sottoriva · 2016 · The Journal of Pathology
43. Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease
    Crispin T. Hiley, John P. C. Le Quesne, George Santis, Rowena Sharpe, David González de Castro, Gary Middleton, Charles Swanton · 2016 · The Lancet
44. Combating subclonal evolution of resistant cancer phenotypes
    Samuel W. Brady, Jasmine A. McQuerry, Yi Qiao, Stephen Piccolo, Gajendra Shrestha, David F. Jenkins, Ryan M. Layer, Brent S. Pedersen, R.H. Miller, Amanda M. Esch et al. · 2017 · Nature Communications
45. A narrative review of tumor heterogeneity and challenges to tumor drug therapy
    Liang Wei Zhu, Minlin Jiang, Hao Wang, Hui Sun, Jun Zhu, Wencheng Zhao, Qiyu Fang, Jia Yu, Peixin Chen, Shengyu Wu et al. · 2021 · Annals of Translational Medicine
46. Therapy-induced APOBEC3A drives evolution of persistent cancer cells
    Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi, Naveed Nikpour, Marcello Stanzione, Sunwoo Oh, Adam Langenbucher, Susanna Monroe, Wenjia Su, Heidie Frisco Cabanos et al. · 2023 · Nature
47. A step-by-step microRNA guide to cancer development and metastasis
    Georgios S. Markopoulos, Eugenia Roupakia, Maria Tokamani, Evangelia Chavdoula, Maria Hatziapostolou, Christos Polytarchou, Kenneth B. Marcu, Athanasios G. Papavassiliou, Raphael Sandaltzopoulos, Evangelos Kolettas · 2017 · Cellular Oncology
48. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity
    Tae‐Min Kim, Seung‐Hyun Jung, Chang Hyeok An, Sung Hak Lee, In-Pyo Baek, Min Sung Kim, Sung‐Won Park, Je‐Keun Rhee, Sug-Hyung Lee, Yeun‐Jun Chung · 2015 · Clinical Cancer Research
49. Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer
    Giulia Siravegna, Luca Lazzari, Giovanni Crisafulli, Andrea Sartore Bianchi, Benedetta Mussolin, Andrea Cassingena, Cosimo Martino, Richard Burnham Lanman, Rebecca J. Nagy, Stephen R. Fairclough et al. · 2018 · Cancer Cell
50. Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer
    Levy-Jurgenson, Alona, Tekpli, Xavier, Kristensen, Vessela N., Yakhini, Zohar · 2020 · Scientific Reports
51. Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution
    Ryutaro Uchi, Yusuke Takahashi, Atsushi Niida, Teppei Shimamura, Hidenari Hirata, Keishi Sugimachi, Genta Sawada, Takeshi Iwaya, Junji Kurashige, Yoshiaki Shinden et al. · 2016 · PLoS Genetics
52. Between-region genetic divergence reflects the mode and tempo of tumor evolution
    Ruping Sun, Zheng Hu, Andrea Sottoriva, Trevor A. Graham, Arbel Harpak, Zhicheng Ma, Jared M. Fischer, Darryl K. Shibata, Christina N. Curtis · 2017 · Nature Genetics
53. The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis
    Gabriel J. Starrett, Elizabeth M. Luengas, Jennifer L. McCann, Diako Ebrahimi, Nuri A. Temiz, Robin P. Love, Yuqing Feng, Madison B. Adolph, Linda Chelico, Emily K. Law et al. · 2016 · Nature Communications
54. Genomic landscape of adenoid cystic carcinoma of the breast
    Luciano Gastón Martelotto, Maria Rosaria De Filippo, Charlotte K.Y. Ng, Rachael Natrajan, Laetitia Fuhrmann, Joanna Cyrta, Salvatore Piscuoglio, Huei‐Chi Wen, Raymond S. Lim, Ronglai Shen et al. · 2015 · The Journal of Pathology
55. Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression
    Howard Hua Yang, P. Charles Lin · 2017 · Seminars in Cancer Biology
56. Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer
    Charles Ricordel, Luc Friboulet, Francesco Facchinetti, Jean‐Charles Soria · 2017 · Annals of Oncology
57. Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
    Subramanian Venkatesan, Rachel Rosenthal, Nnennaya Kanu, Nicholas McGranahan, Jiří Bártek, Sergio A. Quezada, Jonathan Hare, Reuben S. Harris, Charles Swanton · 2018 · Annals of Oncology
58. Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases
    Paul K. Paik, Ronglai Shen, Helen H. Won, Natasha Rekhtman, Lu Wang, Camelia S. Sima, Arshi Arora, Venkatraman Seshan, Marc Ladanyi, Michael F. Berger et al. · 2015 · Cancer Discovery
59. Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing
    Xi-Xi Chen, Qian Zhong, Yang Liu, Shu-mei Yan, Zhang-Hua Chen, Shanzhao Jin, Tianliang Xia, Ruoyan Li, Ai-Jun Zhou, Zhe Su et al. · 2017 · Nature Communications
60. Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
    Merino, D., Weber, T. S., Serrano, A., Vaillant, F., Liu, K., Pal, B., Di Stefano, L., Schreuder, J., Lin, D., Chen, Y. et al. · 2019 · Nature Communications
61. Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
    Evgeny Izumchenko, Xiaofei Chang, Mariana Brait, Elana Judith Fertig, Luciane Tsukamoto Kagohara, Atul Bedi, Luigi Marchionni, Nishant Agrawal, Rajani K. Ravi, Siân Jones et al. · 2015 · Nature Communications
62. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo
    Emily K. Law, Rena Levin-Klein, Matthew C. Jarvis, Hyoung Kim, Prokopios P. Argyris, Michael A. Carpenter, Gabriel J. Starrett, Nuri A. Temiz, Lindsay K. Larson, Cameron C. Durfee et al. · 2020 · The Journal of Experimental Medicine
63. Principles of Reconstructing the Subclonal Architecture of Cancers
    Stefan C. Dentro, David C. Wedge, Peter Van Loo · 2017 · Cold Spring Harbor Perspectives in Medicine
64. Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes
    Ikram Ullah, Govindasamy-Muralidharan Karthik, Amjad Alkodsi, Una Kjällquist, Gustav Stålhammar, John Lövrot, Nelson-Fuentes Martinez, Jens Lagergren, Sampsa Hautaniemi, Johan Hartman et al. · 2018 · Journal of Clinical Investigation
65. The National Lung Matrix Trial of personalized therapy in lung cancer
    Gary Middleton, Peter Fletcher, Sanjay Popat, Joshua Savage, Yvonne Summers, Alastair Greystoke, David Gilligan, Judith Cave, Noelle O'Rourke, Alison E. Brewster et al. · 2020 · Nature
66. Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
    Phuong H. D. Nguyen, Siming Ma, Cheryl Zi Jin Phua, Neslihan Arife Kaya, Hannah L. H. Lai, Chun Jye Lim, Jia Qi Lim, Martin Wasser, Liyun Lai, Wai Leong Tam et al. · 2021 · Nature Communications
67. Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression
    Daniele Tavernari, Elena Battistello, Elie Dheilly, Aaron S. Petruzzella, Marco Mina, Jessica Sordet‐Dessimoz, Solange Peters, Thorsten Krueger, David Gfeller, Nicolò Riggi et al. · 2021 · Cancer Discovery
68. Using tumour phylogenetics to identify the roots of metastasis in humans
    Kamila Naxerova, Rakesh K. Jain · 2015 · Nature Reviews Clinical Oncology
69. Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness
    Alexander Nguyen, Mitsukuni Yoshida, Hani Goodarzi, Sohail F. Tavazoie · 2016 · Nature Communications
70. High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer
    Gloria Vittone Echeverria, Emily Powell, Sahil Seth, Zhongqi Ge, Alessandro Carugo, Christopher Aaron Bristow, Michael D. Peoples, Frederick Scott Robinson, Huan Qiu, Jiansu Shao et al. · 2018 · Nature Communications
71. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies
    Jake June-Koo Lee, Yoon‐La Choi, Mijung Kwon, Peter J. Park · 2016 · Annual Review of Pathology Mechanisms of Disease
72. Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
    Mathilde Borg Houlberg Thomsen, Iver Nordentoft, Philippe Lamy, Søren Vang, Line Sinnathamby Reinert, Christophe K. Mapendano, S. Høyer, Torben Falck Orntoft, Jørgen Bjerggaard Jensen, Lars Dyrskjøt · 2017 · Scientific Reports
73. Tobacco Smoking and Risk of Second Primary Lung Cancer
    Jacqueline V. Aredo, Sophia J. Luo, Rebecca M. Gardner, Nilotpal Sanyal, Eunji Choi, Thomas P. Hickey, Thomas L. Riley, Wen‐Yi Huang, Allison W. Kurian, Ann N. C. Leung et al. · 2021 · Journal of Thoracic Oncology
74. APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation
    David W. Cescon, Benjamin Haibe‐Kains, Tak W. Mak · 2015 · Proceedings of the National Academy of Sciences
75. Stability-driven nonnegative matrix factorization to interpret spatial gene expression and build local gene networks
    Siqi Wu, Antony Joseph, Ann S. Hammonds, S Celniker, Bin Yu, Erwin Frise · 2016 · Proceedings of the National Academy of Sciences
76. Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
    Charlotte K.Y. Ng, Luciano Gastón Martelotto, Arnaud Gauthier, Huei‐Chi Wen, Salvatore Piscuoglio, Raymond S. Lim, Catherine F. Cowell, Paul M Wilkerson, Patty T. Wai, Daniel Nava Rodrigues et al. · 2015 · Genome biology
77. Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies
    Mina, Marco, Raynaud, Franck, Tavernari, Daniele, Battistello, Elena, Sungalee, Stephanie, Saghafinia, Sadegh, Laessle, Titouan, Sanchez-Vega, Francisco, Schultz, Nikolaus, Oricchio, Elisa et al. · 2017 · Cancer Cell
78. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
    Xing Hua, Zhao Wei, Angela Cecilia Pesatori, Dario Consonni, Neil E. Caporaso, Tongwu Zhang, Bin Zhu, Mingyi Wang, Kristine M. Jones, Belynda D. Hicks et al. · 2020 · Nature Communications
79. Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study
    Tomoya Kawaguchi, Yasuhiro Koh, Masahiko Ando, Norimasa Ito, Sadanori Takeo, Hirofumi Adachi, Tsutomu Tagawa, Seiichi Kakegawa, Motohiro Yamashita, Kazuhiko Kataoka et al. · 2016 · Journal of Clinical Oncology
80. Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples
    Luciano Gastón Martelotto, Timour Baslan, Jude Kendall, Felipe Correa Geyer, Kathleen A. Burke, Lee Spraggon, Salvatore Piscuoglio, Kalyani Chadalavada, Gouri J. Nanjangud, Charlotte K.Y. Ng et al. · 2017 · Nature Medicine
81. Effect Sizes of Somatic Mutations in Cancer
    Vincent L. Cannataro, Stephen G. Gaffney, Jeffrey P. Townsend · 2018 · JNCI Journal of the National Cancer Institute
82. Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization
    Shannon L. Werner, Ryon P. Graf, Mark Andrew Landers, David T. Valenta, Matthew J. Schroeder, Stephanie B. Greene, Natalee Bales, Ryan Vance Dittamore, Dena C. Marrinucci · 2015 · Journal of Circulating Biomarkers
83. Tumour Cell Heterogeneity
    Laura J. Gay, Ann‐Marie Baker, Trevor A. Graham · 2016 · F1000Research
84. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
    Heather Scharpenseel, Annkathrin Hanssen, Sonja Loges, Malte Mohme, Christian Bernreuther, Sven Peine, Katrin Lamszus, Y. Goy, Cordula Petersen, Manfred Westphal et al. · 2019 · Scientific Reports
85. Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma
    Gabriel J. Starrett, Christina Marcelus, Paul G. Cantalupo, Joshua P. Katz, Jingwei Cheng, Keiko Akagi, Manisha Thakuria, Guilherme Rabinowits, Linda C. Wang, David E. Symer et al. · 2017 · mBio
86. AID/APOBEC deaminases and cancer
    Stefan Rebhandl, Michael Huemer, Richard Greil, Roland Geisberger · 2015 · Oncoscience
87. Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment
    Sara Saab, Hussein Zalzale, Zahraa Rahal, Yara Khalifeh, Ansam F. Sinjab, Humam N. Kadara · 2020 · Frontiers in Immunology
88. Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
    Min Zhang, Jinli Luo, Qianqian Sun, James Harber, Alan G. Dawson, Apostolos Nakas, Sara Busacca, Annabel Jane Sharkey, David A. Waller, Michael T. Sheaff et al. · 2021 · Nature Communications
89. Tumor Clonality and Resistance Mechanisms in EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Implications for Therapeutic Sequencing
    Shinji Kohsaka, Mark P. Petronczki, Flavio Solca, Makoto Maemondo · 2018 · Future Oncology
90. FUNMarker: Fusion Network-Based Method to Identify Prognostic and Heterogeneous Breast Cancer Biomarkers
    Xingyi Li, Ju Xiang, Jianxin Wang, Jinyan Li, Fang‐Xiang Wu, Min Li · 2020 · IEEE Transactions on Computational Biology and Bioinformatics
91. APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer
    Manikandan Periyasamy, Hetal Patel, Chun‐Fui Lai, Van T.M. Nguyen, Ekaterina Nevedomskaya, Alison Harrod, Roslin Russell, Judit Reményi, Anna Maria Ochocka, Ross S. Thomas et al. · 2015 · Cell Reports
92. A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer
    Tomoko Saito, Atsushi Niida, Ryutaro Uchi, Hidenari Hirata, Hisateru Komatsu, Shotaro Sakimura, Shuto Hayashi, Sho Nambara, Yosuke Kuroda, Shuhei Ito et al. · 2018 · Nature Communications
93. A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study
    Han Si, Michael A. Kuziora, Katie Quinn, Elena Helman, Jiabu Ye, Feng Liu, Urban J. Scheuring, Solange Peters, Naiyer A. Rizvi, Philip Z. Brohawn et al. · 2020 · Clinical Cancer Research
94. Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
    Chae, Young Kwang, Davis, Andrew A., Carneiro, Benedito A., Chandra, Sunandana, Mohindra, Nisha, Kalyan, Aparna, Kaplan, Jason, Matsangou, Maria, Pai, Sachin, Costa, Ricardo et al. · 2016 · Oncotarget
95. Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics
    Dearbhaile Catherine Collins, Raghav Sundar, Joline S.J. Lim, Timothy Anthony Yap · 2016 · Trends in Pharmacological Sciences
96. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases
    Charlotte K.Y. Ng, François‐Clément Bidard, Salvatore Piscuoglio, Felipe Correa Geyer, Raymond S. Lim, Ino de Bruijn, Ronglai Shen, Fresia G. Pareja, Samuel Berman, Lu Wang et al. · 2017 · Clinical Cancer Research
97. Mapping the spreading routes of lymphatic metastases in human colorectal cancer
    Chong Zhang, Lin Zhang, Tianlei Xu, Ruidong Xue, Liang Yu, Yue-lu Zhu, Yun‐Long Wu, Qingqing Zhang, Dongdong Li, Shuohao Shen et al. · 2020 · Nature Communications
98. Circulating cell-free DNA for non-invasive cancer management
    Caitlin M. Stewart, Dana W.Y. Tsui · 2018 · Cancer Genetics
99. Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity
    Ao Huang, Xin Zhang, Shao‐Lai Zhou, Ya Cao, Xiaowu Huang, Jia Fan, Xin‐Rong Yang, Jian Zhou · 2016 · Journal of Cancer
100. The translational challenges of precision oncology
     Oriol Pich, Chris Bailey, Thomas B.K. Watkins, Simone Zaccaria, Mariam Jamal‐Hanjani, Charles Swanton · 2022 · Cancer Cell